Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Sirolimus can reduce tumor cell size in TSC-related skin tumors, but continuous treatment is needed to maintain benefits.

A protein complex called mTORC1 likely affects when hair growth starts in mice.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

Topical melatonin may reduce skin aging by inhibiting certain cellular pathways.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

In 2017, pediatric dermatology advanced with new treatments and insights into various skin conditions in children.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Tacrolimus can cause hair loss in kidney transplant patients.

A woman developed thick gums from everolimus treatment after a kidney transplant.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

The hair follicle dermal sheath is essential for hair shedding and needs to communicate with the outer root sheath for normal hair growth cycles.

PRC1 influences skin stem cell development by both turning genes on and off, affecting hair growth and skin cell types.

Blocking JAK-STAT5 signaling in mice leads to hair growth.

A woman was allergic to quinine in her anti-hair loss lotion.